Sign in

You're signed outSign in or to get full access.

PI

PYXUS INTERNATIONAL, INC. (PYYX)·Q1 2026 Earnings Summary

Executive Summary

  • Q1 FY26 was in line with internal expectations; management reiterated FY26 guidance of $2.3B–$2.5B revenue and $205M–$235M adj. EBITDA, highlighting a normalized cycle with buying 1H and shipments 2H .
  • Revenue fell 19.9% YoY to $508.8M on shipment pull-forward into Q4 FY25; pricing per kilo increased, and processing revenue rose, but regional/customer mix modestly compressed gross margin to 12.9% .
  • Profitability reset seasonally: operating income was $21.0M, EPS was $(0.62), and adj. EBITDA was $29.5M; net interest expense improved by ~$3.5M YoY on lower rates and reduced long-term debt .
  • Working capital execution remained a focus: cash conversion cycle improved to 160 days (from 172), inventory replenishment reflects larger crops in South America/Africa; uncommitted processed inventory stayed low at 2.4%, signaling strong demand .
  • Stock catalysts: unchanged FY26 guidance despite softer Q1 seasonal revenue, continued demand/low uncommitted inventory, and normalization of supply (Africa/South America) that support 2H shipment execution .

What Went Well and What Went Wrong

  • What Went Well

    • Guidance held; management emphasized confidence in 2H execution and normalized buy/sell cadence: “buying in the first half... selling in the second half… improving our alignment with customer requirements” .
    • Pricing resilience and processing growth: average price per kilo increased to $6.85 and processing & other revenues rose to $50.2M (+20% YoY) .
    • Cash conversion improved (160 vs 172 days) and net interest expense improved by ~$3.5M YoY, reflecting lower average rates and reduced long-term debt .
    • CEO quote: “We… captured buying opportunities generated by record crop sizes in South America and Africa… We expect this impact to be increasingly visible in the second half” .
  • What Went Wrong

    • Revenue down 19.9% YoY to $508.8M on shipment pull-forward to Q4 FY25; gross margin compressed to 12.9% on regional/customer mix, tempering profitability .
    • Operating income fell to $21.0M (from $40.5M) and EPS declined to $(0.62) (from $0.18) on lower volumes and gross profit .
    • Seasonal working capital build: adjusted free cash flow of $(458.6)M in the quarter; net debt increased YoY alongside inventory replenishment for larger crops .

Financial Results

MetricQ3 FY2025Q4 FY2025Q1 FY2026
Revenue ($USD Millions)$778.3 $501.7 $508.8
Gross Profit ($USD Millions)$116.4 $67.2 $65.6
Gross Margin (%)15.0% 12.9%
Operating Income ($USD Millions)$66.1 $13.7 $21.0
Net Income (Loss) Attrib. ($USD Millions)$18.9 $(5.1) $(15.8)
Diluted EPS ($)$0.74 $(0.20) $(0.62)
Adjusted EBITDA ($USD Millions)$80.5 $28.6 $29.5

YoY comparison for the quarter (Q1):

MetricQ1 FY2025Q1 FY2026
Revenue ($USD Millions)$634.9 $508.8
Gross Profit ($USD Millions)$83.9 $65.6
Gross Margin (%)13.2% 12.9%
Operating Income ($USD Millions)$40.5 $21.0
Diluted EPS ($)$0.18 $(0.62)
Adjusted EBITDA ($USD Millions)$55.0 $29.5

Segment breakdown (Q1):

Leaf SegmentQ1 FY2025Q1 FY2026
Product Revenues ($USD Millions)$589.2 $458.2
Product Gross Profit ($USD Millions)$80.4 $57.4
Kilos Sold (Millions)95.7 66.9
Avg Price per Kilo ($/kg)$6.16 $6.85
Avg Cost per Kilo ($/kg)$5.32 $5.99
Avg Gross Profit per Kilo ($/kg)$0.84 $0.86
Processing & OtherQ1 FY2025Q1 FY2026
Revenues ($USD Millions)$41.8 $50.2
Gross Profit ($USD Millions)$4.4 $7.6
GP %10.5% 15.1%

Selected KPIs and balance sheet:

KPI / BalanceQ1 FY2025Q1 FY2026
Cash Conversion Cycle (days)172 160
Tobacco Inventory ($USD Millions)$980.6 $1,089.8
Processed Inventory ($USD Millions)$605.5 $575.9
Uncommitted Processed Inventory ($USD Millions, %)$14.7 (2.4%) $13.6 (2.4%)
Net Interest Expense ($USD Millions, quarterly)$33.3 $29.8

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Revenue ($USD Billions)FY2026$2.3–$2.5B (6/10/25) $2.3–$2.5B (8/6/25) Maintained
Adjusted EBITDA ($USD Millions)FY2026$205–$235M (6/10/25) $205–$235M (8/6/25) Maintained

Management reiterated 2H weighting for sales and pointed to larger crops and normalized cycle as drivers of execution against guidance .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3 FY25 and Q4 FY25)Current Period (Q1 FY26)Trend
Cycle normalization and shipment timingQ3: timing of shipments supported strong volume; Q4: expect larger crops, plan to replenish inventory and grow again .Explicitly highlighted “buying 1H, selling 2H” normalized cadence; Q1 in line with expected cycle .Improving alignment with customers .
Regional crop dynamics (South America/Africa)Q3: El Niño constrained South America; Q4: anticipate larger crop sizes South America/Africa .“Record crop sizes in South America and Africa” underpin replenishment; more balanced global leaf market expected .Improving supply .
Working capital / cash conversionQ3: CCC improved by 20 days YoY; strong adjusted FCF .Q4: operating cycle accelerated by 38 days YoY .Q1: CCC improved to 160 days (from 172) .
Tariffs / macroQ4: guidance range reflected tariff assumptions .Q1: “highly dynamic and competitive market”; risk disclosures continue to include tariffs/macro .Watchful/unchanged risk posture .
Pricing/mix and processingQ3: higher ASPs and favorable mix raised GP/kg to $0.91 .Q1: ASP up to $6.85/kg; processing revenues +20% YoY; GP% in processing up .Mixed: price/processing up; GM pressured by region/customer mix .

Management Commentary

  • “We are pleased to report first quarter results that align with our financial expectations and position the business to achieve our full-year guidance… [reflecting] a more normalized cycle—buying in the first half… and selling in the second half” — Pieter Sikkel, CEO .
  • “We… captured buying opportunities generated by record crop sizes in South America and Africa… [to] satisfy continued strong customer demand… increasingly visible in the second half” — Pieter Sikkel, CEO .
  • Slides reinforced confidence: normalized cycle, increased seasonal borrowing capacity (+$200M YoY) and improved flexibility with ABL; no outstanding ABL balance vs. $44M last year .

Q&A Highlights

  • The company cautioned that unauthorized call transcripts may not accurately reflect contents and prohibits unauthorized reproductions; Pyxus made an archived recording available via its IR site after the call .
  • Public transcript links (third-party) for reference: Seeking Alpha (Aug 6–7, 2025) , MarketScreener (S&P Capital IQ) , GuruFocus .
  • We were unable to retrieve the full transcript text via the document tools; themes above are drawn from the company’s prepared remarks and slides .

Estimates Context

  • Wall Street consensus (S&P Global) for Q1 FY26 was not available for EPS and revenue; thus, beat/miss vs. consensus cannot be assessed. The company characterized results as in line with internal expectations . Values retrieved from S&P Global.*
MetricQ1 FY2026 ConsensusQ1 FY2026 Actual
Revenue ($USD Millions)N/A*$508.8
Primary EPS ($)N/A*$(0.62)

*Values retrieved from S&P Global.

Where estimates are unavailable, we anchor to management guidance: FY26 revenue $2.3–$2.5B and adj. EBITDA $205–$235M maintained .

Key Takeaways for Investors

  • Seasonal trough consistent with normalized cycle; focus remains on 2H shipments to drive FY26 guidance delivery .
  • Pricing and processing support unit economics; watch gross margin mix as volumes shift by region/customer through 2H .
  • Execution on working capital and lower interest burden are positive; net interest improved YoY and CCC improved despite inventory rebuild .
  • Low uncommitted processed inventory and larger crops in South America/Africa underpin demand visibility and supply availability into 2H .
  • No change to FY26 guide de-risks near term; delivery hinges on logistics/tariff backdrop and customer timing; guidance embeds dynamic trade assumptions .
  • Short-term trading: shares may react to confirmation of 2H shipment cadence and any incremental tariff headlines; absence of estimate benchmarks limits beat/miss narrative .
  • Medium-term: if supply normalization persists and mix improves, EBITDA and leverage trajectory can continue to strengthen into FY26 exit and FY27 setup .